The Role of Distinct T Cell Subsets in Periodontitis—Studies from Humans and Rodent Models

Current Oral Health Reports

Volumn 1, Issue 2, 2014, Pages 114-123

  Okui, Takafumi ^a   Aoki Nonaka, Yukari ^a   Nakajima, Takako ^b   Yamazaki, Kazuhisa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

CD4+ helper T cell; CD8+ cytotoxic T cell; Human specimen; NKT cell; Periodontal disease; Periodontitis; Regulatory T cell (Treg); Rodent model with periodontitis; T cell; T cell subset; Th1; Th17; Th2

Indexed keywords

EID: 84940892129     PISSN: None     EISSN: 21963002     Source Type: Journal    
DOI: 10.1007/s40496-014-0013-z     Document Type: Review

References (97)

1. Gemmell E, Yamazaki K, Seymour GJ. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000. 2007;43:14–40. DOI: 10.1111/j.1600-0757.2006.00173.x
2. Yamazaki K, Nakajima T. Antigen specificity and T-cell clonality in periodontal disease. Periodontol 2000. 2004;35:75–100. DOI: 10.1111/j.0906-6713.2004.003558.x
3. Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H, Hara K. Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients. Clin Exp Immunol. 2000;120(2):285–93. DOI: 10.1046/j.1365-2249.2000.01216.x
4. Hirsch HZ, Tarkowski A, Miller EJ, Gay S, Koopman WJ, Mestecky J. Autoimmunity to collagen in adult periodontal disease. J Oral Pathol. 1988;17(9–10):456–9. DOI: 10.1111/j.1600-0714.1988.tb01315.x
5. Yamazaki K, Ohsawa Y, Tabeta K, Ito H, Ueki K, Oda T, et al. Accumulation of human heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect Immun. 2002;70(5):2492–501. DOI: 10.1128/IAI.70.5.2492-2501.2002
6. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res. 2010;89(12):1349–63. DOI: 10.1177/0022034510376402
7. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. 1999;67(6):2804–9.
8. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000;106(6):R59–67. DOI: 10.1172/JCI10763
9. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Ávila-Campos MJ, Cunha FQ, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol. 2006;21(1):12–20. DOI: 10.1111/j.1399-302X.2005.00245.x
10. + Th-cell-mediated alveolar bone destruction in vivo. Infect Immun. 2005;73(6):3453–61. DOI: 10.1128/IAI.73.6.3453-3461.2005
11. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol. 2000;164(4):2102–9. DOI: 10.4049/jimmunol.164.4.2102
12. Myneni SR, Settem RP, Connell TD, Keegan AD, Gaffen SL, Sharma A. TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol. 2011;187(1):501–9. DOI: 10.4049/jimmunol.1100683
13. Liu C, Hashizume T, Kurita-Ochiai T, Fujihashi K, Yamamoto M. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity. Mol Oral Microbiol. 2010;25(3):178–89. DOI: 10.1111/j.2041-1014.2009.00560.x
14. Alayan J, Ivanovski S, Farah CS. Alveolar bone loss in T helper 1/T helper 2 cytokine-deficient mice. J Periodontal Res. 2007;42(2):97–103. DOI: 10.1111/j.1600-0765.2006.00920.x
15. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007;109(9):3794–802. DOI: 10.1182/blood-2005-09-010116
16. de Brito BB, Andriankaja O, Kang J, Pacios S, Bae HJ, Li Y, et al. A.actinomycetemcomitans-induced periodontal disease promotes systemic and local responses in rat periodontium. J Clin Periodontol. 2012;39(4):333–41. DOI: 10.1111/j.1600-051X.2011.01847.x
17. Garlet GP, Cardoso CR, Mariano FS, Claudino M, de Assis GF, Campanelli AP, et al. Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol. 2010;37(7):591–600. DOI: 10.1111/j.1600-051X.2010.01586.x
18. Wang L, Wang J, Jin Y, Gao H, Lin X. Oral administration of all-trans retinoic acid suppresses experimental periodontitis by modulating the Th17/Treg imbalance. J Periodontol. 2013. doi:10.1902/jop.2013.130132. This study demonstrated that all-trans retinoic acid suppressed alveolar bone destruction in experimental periodontitis through modulating the Th17/Treg balance, suggesting a new therapeutic approach for the prevention of periodontitis in the context of immune modulation.
19. Glowacki AJ, Yoshizawa S, Jhunjhunwala S, Vieira AE, Garlet GP, Sfeir C, et al. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci U S A. 2013;110(46):18525–30. This study showed that injection of CCL22-releasing microparticles into gingival tissue suppressed inflammatory bone resorption in experimental murine periodontitis via recruitment of Tregs, suggesting that induction of balanced immune response has a therapeutic potential for the treatment of periodontitis. DOI: 10.1073/pnas.1302829110
20. Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman M, Stashenko P. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res. 2004;39(6):432–41. DOI: 10.1111/j.1600-0765.2004.00760.x
21. +-Th1-cell-associated alveolar bone loss in vivo. Infect Immun. 2006;74(8):4927–31. DOI: 10.1128/IAI.00491-06
22. Aoki-Nonaka Y, Nakajima T, Miyauchi S, Miyazawa H, Yamada H, Domon H, et al. Natural killer T cells mediate alveolar bone resorption and a systemic inflammatory response in response to oral infection of mice with Porphyromonas gingivalis. J Periodontal Res. 2014;49(1):69–76. This study demonstrated the pathogenic role of NKT cells in pathogen-induced experimental periodontitis by analyzing mice with either a deficiency or activation of NKT cells.
23. Cole KL, Seymour GJ, Powell RN. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol. 1987;58(8):569–73. DOI: 10.1902/jop.1987.58.8.569
24. Stoufi ED, Taubman MA, Ebersole JL, Smith DJ, Stashenko PP. Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues. J Clin Immunol. 1987;7(3):235–45. DOI: 10.1007/BF00915729
25. Johannessen AC, Nilsen R, Kristoffersen T, Knudsen GE. Variation in the composition of gingival inflammatory cell infiltrates. J Clin Periodontol. 1990;17(5):298–305. DOI: 10.1111/j.1600-051X.1990.tb01093.x
26. Jully JM, Bene MC, Martin G, Faure G. Immunohistological identification of cell subsets in human gingiva after local treatment for gingivitis or periodontitis. J Clin Periodontol. 1986;13(3):223–7. DOI: 10.1111/j.1600-051X.1986.tb01464.x
27. Syrjanen S, Markkanen H, Syrjanen K. Inflammatory cells and their subsets in lesions of juvenile periodontitis. A family study. Acta Odontol Scand. 1984;42(5):285–92. DOI: 10.3109/00016358408993882
28. Modeer T, Dahllof G, Axio E, Sundqvist KG. Subpopulations of lymphocytes in connective tissue from adolescents with periodontal disease. Acta Odontol Scand. 1990;48(3):153–9. DOI: 10.3109/00016359009005870
29. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J Clin Periodontol. 1999;26(3):183–9. DOI: 10.1034/j.1600-051X.1999.260309.x
30. Reinhardt RA, Bolton RW, McDonald TL, DuBois LM, Kaldahl WB. In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol. 1988;59(10):656–70. DOI: 10.1902/jop.1988.59.10.656
31. + T cell differentiation, anergy and memory with implications for vaccines. Trends Mol Med. 2010;16(10):478–91. DOI: 10.1016/j.molmed.2010.07.007
32. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8–18. DOI: 10.1016/j.ajpath.2012.03.044
33. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673–82. DOI: 10.1084/jem.20061775
34. Okamoto K, Takayanagi H. Regulation of bone by the adaptive immune system in arthritis. Arthritis Res Ther. 2011;13(3):219. This review excellently describes the functional role of each T cell subset, particularly focusing on the Th17 subset, in osteoclastogenesis and inflammatory bone destruction. DOI: 10.1186/ar3323
35. Aoyagi T, Sugawara-Aoyagi M, Yamazaki K, Hara K. Interleukin 4 (IL-4) and IL-6-producing memory T-cells in peripheral blood and gingival tissue in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol Immunol. 1995;10(5):304–10. DOI: 10.1111/j.1399-302X.1995.tb00159.x
36. Gemmell E, Seymour GJ. Cytokines and T cell switching. Crit Rev Oral Biol Med. 1994;5(3–4):249–79.
37. Manhart SS, Reinhardt RA, Payne JB, Seymour GJ, Gemmell E, Dyer JK, et al. Gingival cell IL-2 and IL-4 in early-onset periodontitis. J Periodontol. 1994;65(9):807–13. DOI: 10.1902/jop.1994.65.9.807
38. Reinhardt RA, McDonald TL, Bolton RW, DuBois LM, Kaldahl WB. IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol. 1989;60(1):44–50. DOI: 10.1902/jop.1989.60.1.44
39. Sigusch B, Klinger G, Glockmann E, Simon HU. Early-onset and adult periodontitis associated with abnormal cytokine production by activated T lymphocytes. J Periodontol. 1998;69(10):1098–104. DOI: 10.1902/jop.1998.69.10.1098
40. Tokoro Y, Matsuki Y, Yamamoto T, Suzuki T, Hara K. Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol. 1997;107(1):166–74. DOI: 10.1046/j.1365-2249.1997.d01-880.x
41. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000. 1994;5:112–41. DOI: 10.1111/j.1600-0757.1994.tb00021.x
42. Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res. 2000;79(8):1548–55. DOI: 10.1177/00220345000790080401
43. Ukai T, Mori Y, Onoyama M, Hara Y. Immunohistological study of interferon-γ- and interleukin-4-bearing cells in human periodontitis gingiva. Arch Oral Biol. 2001;46(10):901–8. DOI: 10.1016/S0003-9969(01)00057-7
44. Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ. T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol. 1999;44(12):1045–53.
45. Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J Periodontol. 1996;67(5):515–22. DOI: 10.1902/jop.1996.67.5.515
46. Wassenaar A, Reinhardus C, Thepen T, Abraham-Inpijn L, Kievits F. Cloning, characterization, and antigen specificity of T-lymphocyte subsets extracted from gingival tissue of chronic adult periodontitis patients. Infect Immun. 1995;63(6):2147–53.
47. Yamamoto M, Fujihashi K, Hiroi T, McGhee JR, Van Dyke TE, Kiyono H. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res. 1997;32(1 Pt 2):115–9. DOI: 10.1111/j.1600-0765.1997.tb01391.x
48. Berglundh T, Liljenberg B, Lindhe J. Some cytokine profiles of T-helper cells in lesions of advanced periodontitis. J Clin Periodontol. 2002;29(8):705–9. DOI: 10.1034/j.1600-051X.2002.290807.x
49. Gemmell E, Grieco DA, Cullinan MP, Westerman B, Seymour GJ. The proportion of interleukin-4, interferon-gamma and interleukin-10-positive cells in Porphyromonas gingivalis-specific T-cell lines established from P. gingivalis-positive subjects. Oral Microbiol Immunol. 1999;14(5):267–74. DOI: 10.1034/j.1399-302X.1999.140501.x
50. Honda T, Aoki Y, Takahashi N, Maekawa T, Nakajima T, Ito H, et al. Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin Chim Acta. 2008;395(1–2):137–41. DOI: 10.1016/j.cca.2008.06.003
51. Ohyama H, Kato-Kogoe N, Kuhara A, Nishimura F, Nakasho K, Yamanegi K, et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res. 2009;88(7):633–8. DOI: 10.1177/0022034509339889
52. Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Júnior WM, Rossi MA, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009;24(1):1–6. DOI: 10.1111/j.1399-302X.2008.00463.x
53. Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol. 2007;78(8):1545–50. DOI: 10.1902/jop.2007.060458
54. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol. 2005;32(4):383–9. DOI: 10.1111/j.1600-051X.2005.00684.x
55. Moutsopoulos NM, Kling HM, Angelov N, Jin W, Palmer RJ, Nares S, et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun. 2012;39(4):294–303. DOI: 10.1016/j.jaut.2012.03.003
56. Szkaradkiewicz AK, Karpinski TM, Zeidler A, Wyganowska-Swiatkowska M, Szkaradkiewicz A. Protective effect of oral Lactobacilli in pathogenesis of chronic periodontitis. J Physiol Pharmacol: Off J Pol Physiol Soc. 2011;62(6):685–9.
57. Dutzan N, Vernal R, Vaque JP, García-Sesnich J, Hernandez M, Abusleme L, et al. Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol. 2012;83(7):948–54. DOI: 10.1902/jop.2011.110482
58. + T cell lines that were established from gingival tissue or peripheral blood of patients.
59. Duarte PM, Santos VR, Dos Santos FA, de Lima Pereira SA, Rodrigues DB, Napimoga MH. Role of smoking and type 2 diabetes in the immunobalance of advanced chronic periodontitis. J Periodontol. 2011;82(3):429–38. DOI: 10.1902/jop.2010.100215
60. Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, Behfarnia P, Shahabuei M, Rafiee L. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res. 2012;47(4):525–31. DOI: 10.1111/j.1600-0765.2011.01464.x
61. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res. 2010;89(9):943–7. DOI: 10.1177/0022034510369297
62. + T cells of periodontitis patients. DOI: 10.1111/j.1600-051X.2011.01712.x
63. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171(11):6173–7. DOI: 10.4049/jimmunol.171.11.6173
64. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198(12):1951–7. DOI: 10.1084/jem.20030896
65. Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol. 2009;27:551–89. DOI: 10.1146/annurev.immunol.021908.132723
66. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18–20. DOI: 10.1038/83707
67. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68–73. DOI: 10.1038/83784
68. Takeuchi Y, Yoshie H, Hara K. Expression of interleukin-2 receptor and HLA-DR on lymphocyte subsets of gingival crevicular fluid in patients with periodontitis. J Periodontal Res. 1991;26(6):502–10. DOI: 10.1111/j.1600-0765.1991.tb01802.x
69. Nakajima T, Ueki-Maruyama K, Oda T, Ohsawa Y, Ito H, Seymour GJ, et al. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res. 2005;84(7):639–43. DOI: 10.1177/154405910508400711
70. + natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol. 2008;84(1):311–8. DOI: 10.1189/jlb.0108014
71. Kim YC, Ko Y, Hong SD, Kim KY, Lee YH, Chae C, et al. Presence of Porphyromonas gingivalis and plasma cell dominance in gingival tissues with periodontitis. Oral Dis. 2010;16(4):375–81. DOI: 10.1111/j.1601-0825.2009.01649.x
72. +) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol. 2007;148(2):271–80. DOI: 10.1111/j.1365-2249.2006.03318.x
73. + regulatory T cells under inflammatory or non-inflammatory conditions. Semin Immunol. 2011;23(6):424–30. DOI: 10.1016/j.smim.2011.10.002
74. Gemmell E, McHugh GB, Grieco DA, Seymour GJ. Costimulatory molecules in human periodontal disease tissues. J Periodontal Res. 2001;36(2):92–100. DOI: 10.1034/j.1600-0765.2001.360205.x
75. Orima K, Yamazaki K, Aoyagi T, Hara K. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol. 1999;115(1):153–60. DOI: 10.1046/j.1365-2249.1999.00763.x
76. Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K. Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol. 1997;12(5):281–7. DOI: 10.1111/j.1399-302X.1997.tb00392.x
77. Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF. Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol. 2001;123(2):294–300. DOI: 10.1046/j.1365-2249.2001.01448.x
78. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-β1 in chronically-inflamed periodontal tissue. J Clin Periodontol. 1999;26(6):366–73. DOI: 10.1034/j.1600-051X.1999.260606.x
79. Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-κB ligand, interleukin (IL) -17, IL-10 and transforming growth factor-β during the progression of chronic periodontitis. J Clin Periodontol. 2009;36(5):396–403. DOI: 10.1111/j.1600-051X.2009.01390.x
80. + T-cell clones established from chronic inflammatory lesions. Oral Microbiol Immunol. 2008;23(1):49–54.
81. + T-cell clones derived from gingival tissues of periodontitis patients. Oral Microbiol Immunol. 2005;20(6):382–6. DOI: 10.1111/j.1399-302X.2005.00241.x
82. + T cells. Eur J Immunol. 2007;37(1):129–38. DOI: 10.1002/eji.200636435
83. pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112(6):2340–52. DOI: 10.1182/blood-2008-01-133967
84. H17 cells. Clin Immunol. 2009;131(2):298–307. DOI: 10.1016/j.clim.2008.12.008
85. + Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A. 2010;107(45):19402–7. DOI: 10.1073/pnas.1008247107
86. + Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin. J Invest Dermatol. 2011;131(9):1853–60. DOI: 10.1038/jid.2011.139
87. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011;140(3):957–65. DOI: 10.1053/j.gastro.2010.12.002
88. + T cells in inflammatory bowel disease and colon cancer. Clin Immunol. 2013;148(2):246–53. DOI: 10.1016/j.clim.2013.05.003
89. Lawson V. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells. Immunology. 2012;137(1):20–7. DOI: 10.1111/j.1365-2567.2012.03612.x
90. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol. 2006;7(9):978–86. DOI: 10.1038/ni1380
91. Mattner J, Debord KL, Ismail N, Goff RD, Cantu III C, Zhou D, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005;434(7032):525–9. DOI: 10.1038/nature03408
92. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol. 2011;12(10):966–74. DOI: 10.1038/ni.2096
93. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol. 2011;12(12):1202–11. DOI: 10.1038/ni.2143
94. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol. 2007;5(6):405–17. DOI: 10.1038/nrmicro1657
95. Yamazaki K, Ohsawa Y, Yoshie H. Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases. Am J Pathol. 2001;158(4):1391–8. DOI: 10.1016/S0002-9440(10)64090-4
96. Amanuma R, Nakajima T, Yoshie H, Yamazaki K. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues. J Periodontal Res. 2006;41(1):73–9. DOI: 10.1111/j.1600-0765.2005.00837.x
97. Nowak M, Krämer B, Haupt M, Papapanou PN, Kebschull J, Hoffmann P, et al. Activation of invariant NK T cells in periodontitis lesions. J Immunol. 2013;190(5):2282–91. DOI: 10.4049/jimmunol.1201215